What is the recommended treatment for an 11-year-old patient with herpes simplex virus (HSV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Simplex Virus in an 11-Year-Old

For an 11-year-old with herpes simplex virus infection, oral acyclovir 20 mg/kg (maximum 400 mg) three times daily for 5-10 days is the recommended treatment, with the specific duration and route depending on the severity and location of infection. 1

Treatment Based on Clinical Presentation

Mild Mucocutaneous HSV (Gingivostomatitis, Cold Sores, or Genital Herpes)

  • Oral acyclovir 20 mg/kg (maximum 400 mg per dose) three times daily for 5-10 days is the standard treatment for children under 45 kg 1
  • Treatment should be initiated at the first sign of symptoms or during the prodrome stage for maximum benefit 2, 3
  • For mild symptomatic gingivostomatitis specifically, this same dosing continues until lesions completely heal 1

Moderate to Severe Mucocutaneous Disease

  • Intravenous acyclovir 5-10 mg/kg three times daily should be initiated for moderate to severe symptomatic gingivostomatitis or extensive disease 1
  • Once lesions begin to regress, transition to oral acyclovir at the same weight-based dosing (20 mg/kg three times daily) and continue until complete healing 1
  • This approach is particularly important for immunocompromised children or those with severe primary infections 4, 5

CNS or Disseminated HSV Disease

  • Intravenous acyclovir 10 mg/kg three times daily for 21 days is required for CNS involvement or disseminated disease in children outside the neonatal period 1
  • This represents a critical distinction from mucocutaneous disease, as CNS involvement carries significant morbidity and mortality risk 1
  • Earlier initiation of therapy (within 4 days of symptom onset) significantly reduces mortality from 28% to 8% 1

Important Clinical Considerations

Dosing Pitfalls

  • The maximum dose of 400 mg per administration applies to children weighing less than 45 kg 1
  • Children who have reached adult weight (≥45 kg) or are postpubertal can receive adult dosing of acyclovir 400 mg three times daily 1
  • Do not use topical acyclovir as it is substantially less effective than oral formulations 1, 3

Duration of Therapy

  • For genital herpes in children, treatment duration is 5-14 days depending on severity 1
  • For orolabial lesions, 7-10 days is standard, though 5-10 days is acceptable for milder cases 3
  • Treatment should continue until lesions completely heal, not just for a fixed number of days 1

Alternative Agents (Limited Pediatric Data)

  • Valacyclovir and famciclovir are approved for adults and adolescents but lack pediatric formulations and dosing data for younger children 1
  • These agents could be considered for older children (postpubertal) who can swallow adult-sized tablets and receive adult dosing 1, 4
  • Valacyclovir 1 gram twice daily or famciclovir 250 mg three times daily are adult doses that may apply to postpubertal adolescents 2

Acyclovir Resistance

  • Suspect resistance if lesions do not begin healing after 7-10 days of appropriate acyclovir therapy 2, 3
  • For proven or suspected acyclovir-resistant HSV, foscarnet 40 mg/kg IV every 8 hours (or 60 mg/kg twice daily) is the treatment of choice 1
  • Resistance is more common in immunocompromised patients receiving chronic suppressive therapy 1

Special Populations

  • Immunocompromised children may require higher doses (acyclovir 400 mg orally 3-5 times daily) and longer treatment courses 6
  • Neonates require different dosing (20 mg/kg IV every 8 hours for 21 days for CNS disease) and are not covered by the standard pediatric recommendations 1

Prevention Counseling

  • Patients should avoid close contact when lesions or prodromal symptoms are present 1, 2, 3
  • For adolescents with genital herpes, latex condoms should be used during every sexual act to reduce transmission risk 1, 2
  • Asymptomatic viral shedding can occur and lead to transmission even without visible lesions 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Genital Herpes Treatment Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oral Acyclovir for Herpes Simplex Cold Sores

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Herpes Simplex Virus in Children.

Current treatment options in neurology, 2002

Research

Treatment of mucocutaneous presentations of herpes simplex virus infections.

American journal of clinical dermatology, 2002

Guideline

Treatment of Severe HSV Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.